Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petco Health & Wellness Company (WOOF) Asset Writedowns and Impairment (2020 - 2025)

Petco Health & Wellness Company's Asset Writedowns and Impairment history spans 6 years, with the latest figure at $155000.0 for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment fell 88.77% year-over-year to $155000.0; the TTM value through Nov 2025 reached $1.0 million, down 88.79%, while the annual FY2025 figure was $8.8 million, 210.27% up from the prior year.
  • Asset Writedowns and Impairment reached $155000.0 in Q4 2025 per WOOF's latest filing, up from $76000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $8.0 million in Q1 2021 to a low of -$307000.0 in Q1 2023.
  • Average Asset Writedowns and Impairment over 5 years is $1.7 million, with a median of $989000.0 recorded in 2021.
  • Peak YoY movement for Asset Writedowns and Impairment: tumbled 106.14% in 2023, then surged 87600.0% in 2024.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $3.2 million in 2021, then crashed by 71.19% to $930000.0 in 2022, then rose by 25.48% to $1.2 million in 2023, then grew by 18.25% to $1.4 million in 2024, then plummeted by 88.77% to $155000.0 in 2025.
  • Per Business Quant, the three most recent readings for WOOF's Asset Writedowns and Impairment are $155000.0 (Q4 2025), $76000.0 (Q3 2025), and $446000.0 (Q2 2025).